Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew Whiteman

Showing results (141-150 of 154) with videos related to

Pageof 16
Sort By:
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 29, 2025
AP39, a novel mitochondria-targeted hydrogen sulfide donor, promotes cutaneous wound healing in an in vivo murine model of acute frostbite injuryGeorge J Dugbartey, Lucas N Penney, Lauren Mills, et al.
European Journal of Pharmacology|June 13, 2026
Corrigendum to "Neuroprotection by post-stroke administration of the slow-releasing hydrogen sulfide (H2S) donor AP39: Long-term functional, MRI, and molecular evidence in a rodent stroke model" [European J. Pharmacol. 1008 (2025) 178331]Bartosz Pomierny, Weronika Krzyżanowska, Alicja Skórkowska, et al.
Oxidative Medicine and Cellular Longevity|March 22, 2018
Hydrogen Sulfide Abrogates Hemoglobin-Lipid Interaction in Atherosclerotic LesionLászló Potor, Péter Nagy, Gábor Méhes, et al.
Biochemical Society Transactions|September 23, 2011
Measurement and meaning of markers of reactive species of oxygen, nitrogen and sulfur in healthy human subjects and patients with inflammatory joint diseasePaul G Winyard, Brent Ryan, Paul Eggleton, et al.
Redox Biology|February 13, 2023
Hydrogen sulfide as an anti-calcification stratagem in human aortic valve: Altered biogenesis and mitochondrial metabolism of H<sub>2</sub>S lead to H<sub>2</sub>S deficiency in calcific aortic valve diseaseZsolt Combi, László Potor, Péter Nagy, et al.
Journal of Cellular Physiology|October 15, 2010
Gene profiling reveals hydrogen sulphide recruits death signaling via the N-methyl-D-aspartate receptor identifying commonalities with excitotoxicityMinghui Jessica Chen, Zhao Feng Peng, Jayapal Manikandan, et al.
Redox Biology|March 13, 2023
Hydrogen sulfide donor AP123 restores endothelial nitric oxide-dependent vascular function in hyperglycemia via a CREB-dependent pathwayRosangela Montanaro, Valentina Vellecco, Roberta Torregrossa, et al.
Gastroenterology|June 3, 2026
Pathology-driven epithelial sulfide loss reprograms the redox proteome and triggers Barrett's esophagusEdyta Korbut, Mateusz Wierdak, Thibaut Vignane, et al.
Shock (Augusta, Ga.)|June 22, 2018
The Mitochondria-Targeted H2S-Donor AP39 in a Murine Model of Combined Hemorrhagic Shock and Blunt Chest TraumaMartin Wepler, Tamara Merz, Ulrich Wachter, et al.
Journal of Neurochemistry|July 5, 2005
Proteasome inhibition by lactacystin in primary neuronal cells induces both potentially neuroprotective and pro-apoptotic transcriptional responses: a microarray analysisElaine Hau Jin Yew, Nam Sang Cheung, Meng Shyan Choy, et al.
Pageof 16

Showing results (141-150 of 154) with videos related to

Sort By:
Pageof 16
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 29, 2025
AP39, a novel mitochondria-targeted hydrogen sulfide donor, promotes cutaneous wound healing in an in vivo murine model of acute frostbite injuryGeorge J Dugbartey, Lucas N Penney, Lauren Mills, et al.
European Journal of Pharmacology|June 13, 2026
Corrigendum to "Neuroprotection by post-stroke administration of the slow-releasing hydrogen sulfide (H2S) donor AP39: Long-term functional, MRI, and molecular evidence in a rodent stroke model" [European J. Pharmacol. 1008 (2025) 178331]Bartosz Pomierny, Weronika Krzyżanowska, Alicja Skórkowska, et al.
Oxidative Medicine and Cellular Longevity|March 22, 2018
Hydrogen Sulfide Abrogates Hemoglobin-Lipid Interaction in Atherosclerotic LesionLászló Potor, Péter Nagy, Gábor Méhes, et al.
Biochemical Society Transactions|September 23, 2011
Measurement and meaning of markers of reactive species of oxygen, nitrogen and sulfur in healthy human subjects and patients with inflammatory joint diseasePaul G Winyard, Brent Ryan, Paul Eggleton, et al.
Redox Biology|February 13, 2023
Hydrogen sulfide as an anti-calcification stratagem in human aortic valve: Altered biogenesis and mitochondrial metabolism of H<sub>2</sub>S lead to H<sub>2</sub>S deficiency in calcific aortic valve diseaseZsolt Combi, László Potor, Péter Nagy, et al.
Journal of Cellular Physiology|October 15, 2010
Gene profiling reveals hydrogen sulphide recruits death signaling via the N-methyl-D-aspartate receptor identifying commonalities with excitotoxicityMinghui Jessica Chen, Zhao Feng Peng, Jayapal Manikandan, et al.
Redox Biology|March 13, 2023
Hydrogen sulfide donor AP123 restores endothelial nitric oxide-dependent vascular function in hyperglycemia via a CREB-dependent pathwayRosangela Montanaro, Valentina Vellecco, Roberta Torregrossa, et al.
Gastroenterology|June 3, 2026
Pathology-driven epithelial sulfide loss reprograms the redox proteome and triggers Barrett's esophagusEdyta Korbut, Mateusz Wierdak, Thibaut Vignane, et al.
Shock (Augusta, Ga.)|June 22, 2018
The Mitochondria-Targeted H2S-Donor AP39 in a Murine Model of Combined Hemorrhagic Shock and Blunt Chest TraumaMartin Wepler, Tamara Merz, Ulrich Wachter, et al.
Journal of Neurochemistry|July 5, 2005
Proteasome inhibition by lactacystin in primary neuronal cells induces both potentially neuroprotective and pro-apoptotic transcriptional responses: a microarray analysisElaine Hau Jin Yew, Nam Sang Cheung, Meng Shyan Choy, et al.
Pageof 16